Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Patient Assistance Program
The Novo Nordisk Patient Assistance Program (PAP) is based on our commitment to people living with diabetes. The Patient Assistance Program provides medication at no cost to those who qualify.
Patients who are approved for the PAP may qualify to receive free diabetes medicine from Novo Nordisk. There is no registration charge or monthly fee for participating.
Click here for a list of our Novo Nordisk products covered by the PAP.
Patient Assistance Program
The Novo Nordisk Patient Assistance Program (PAP) is based on our commitment to people living with diabetes. The Patient Assistance Program provides medication at no cost to those who qualify.
Patients who are approved for the PAP may qualify to receive free diabetes medicine from Novo Nordisk. There is no registration charge or monthly fee for participating.
Click here for a list of our Novo Nordisk products covered by the PAP.
If you have lost your health insurance coverage because of a change in job status due to COVID-19, you may be eligible for a free 90-day supply of insulin. See the "COVID-19 job-loss exceptions" below.
2021 program updates
MEDICARE PART D
Individuals with Medicare Part D coverage may apply for 2022 PAP enrollment after October 15th, 2021. Please complete the latest version of the application available for download below. Be sure to enter the correct enrollment year when completing page 3.
AUTO-REFILL
For added convenience and at the direction of the prescriber, the Novo Nordisk PAP now offers automatic refills for most medications. All new applicants will be automatically enrolled. The medication will ship to the prescriber of an approved enrollee/applicant in accordance with current program guidelines with minimal involvement on behalf of the prescriber. Auto-refills terminate at the end of the patient's program enrollment period. Auto-refills are managed by the prescriber.
See if you qualify for the PAP
Eligibility requirements:
- I am a US citizen or legal resident
- My total household income is at or below 400% of the federal poverty level (FPL). Visit the NeedyMeds website, which lists the current FPL guidelines
- I have no insurance or I have Medicare
- I am not enrolled in and don’t qualify for any other federal, state, or government program such as Medicaid, Low Income Subsidy, or Veterans (VA) Benefits
- Patients who are eligible for Medicaid must sign the Patient Declaration section of the latest version of the PAP application stating they are not enrolled in, plan to enroll in, or are eligible for Medicaid or Medicare Extra Help/LIS (proof of denial must be submitted if requested)
- See eligibility requirements for Minnesota residents
COVID-19 job-loss exceptions:
Application process changes if your benefits have been affected by COVID-19.
Documentation required:
- Completed PAP application
- Documentation showing loss of healthcare benefits (job termination notice, job status change, proof of COBRA benefits being offered)
- No proof of income required
If approved, you will receive a free 90-day supply of insulin. Novo Nordisk will check back with you (before your 90-day enrollment ends) to determine continued eligibility. Assistance can be extended for otherwise eligible patients who have been denied Medicaid coverage.
If this exception doesn’t apply to you, see all options for saving on your Novo Nordisk insulin.
Questions?
See the frequently asked questions below or call Novo Nordisk toll-free at 1-866-310-7549.
Start the application process
Download and fill out the application
Gather proof of income
- Make a copy of one of the following items to show your adjusted gross annual household income:
- 2 most current paycheck stubs or earning statements for all working members of your household
- Last year’s federal Individual Income Tax Return (1040)
- Social Security income, pension, and other income statements
- W-2 or 1099 forms
- Unemployment benefit statements
Take the application and proof of income to your health care provider
- Your health care provider must:
- Complete the Prescriber and Rx sections of the application
- Sign and date the application
- Fax the completed application and proof of income to 1-866-441-4190, or mail them to Novo Nordisk Inc., PO Box 370, Somerville, NJ 08876. Faxes must be sent from your health care provider’s office
Please allow up to 10 business days for processing.
Note:
After the application is reviewed, you and your health care provider will be informed of the decision. If approved, your medicine will be sent to your health care provider’s office, where you can pick it up.
Product availability subject to change without notice.
Novo Nordisk reserves the right to modify or cancel this program at any time without notice.
Important:
- Do not include patient medical records with this application
- Patients who are eligible for Medicaid must sign the Patient Declaration section of the latest version of the PAP application stating they are not enrolled in, plan to enroll in, or are eligible for Medicaid or Medicare Extra Help/LIS (proof of denial must be submitted if requested)
- Applications to participate in PAP by individuals with Medicare must be submitted by November 30th of each calendar year and qualified Medicare patients will be enrolled in the program through December 31st of the calendar year
Eligibility and enrollment
Patients must be a US citizen or legal resident, must have a total household income at or below 400% of the federal poverty level, and must be uninsured or have Medicare.
Uninsured patients are enrolled for 12 months. Medicare patients are enrolled for a calendar year.
No, we no longer require that Medicare Part D patients spend $1000 out of pocket to be eligible for the program.
Application process and approval
If an application is submitted with all supporting documentation and all required fields completed, it will be processed within 2 business days. Any missing or incomplete information may cause a delay.
If approved, patients will receive a letter in the mail. Also, if a patient opts in for automated phone notification on the application, they will receive an automated recorded phone message notification.
Health care providers will receive a letter via fax.
Once approved, a patient's medication should arrive at their prescriber's office within 10-14 business days.
Medication shipment
Unfortunately, we are currently not able to ship directly to patients.
Unfortunately, we are currently not able to ship directly to a pharmacy.
Change of doctor or address
Please contact us at 866-310-7549 so we can provide additional direction.
Please contact us at 866-310-7549 so we can update your records.
Please contact us at 866-310-7549 so we can update your records.
PAP reapplication
Yes. Patients will need to submit a new application and supporting documentation when their enrollment ends if they'd like to be considered for continued support. Patients should be sure to submit the latest version of the application, which is available on this page in the "Patient Assistance Program forms" section above.
Patients may submit a new application 30 days prior to the end of their enrollment. Medicare Part D patients may apply after October 15th of the current year to enroll for the following year.
Find helpful resources
Safe disposal program
It's important to properly dispose of your used Novo Nordisk products.
Get help managing your diabetes
Find tools and resources tailored to your needs at Cornerstones4Care.com.
Tresiba® is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1‑800‑FDA‑1088.
If you need assistance with prescription costs, help may be available. Visit www.pparx.org or call 1-888-4PPA-NOW.
© 2022 Novo Nordisk All rights reserved. US22NC00005 March 2022